Review of Glucose-6-phosphate Dehydrogenase (G6PD): Structural Features, Metabolic Functions, and Research Applications
Review of Glucose-6-phosphate Dehydrogenase (G6PD): Structural Features, Metabolic Functions, and Research Applications
Glucose-6-phosphate dehydrogenase (G6PD) is the key rate-limiting enzyme of the oxidative phase of the pentose phosphate pathway (PPP). It catalyzes the oxidation of glucose-6-phosphate (G6P) to 6-phosphoglucono-δ-lactone while reducing NADP⁺ to NADPH. NADPH is pivotal for antioxidant defense, reductive power supply for biosynthesis, redox signaling regulation, and xenobiotic/drug detoxification. Accordingly, G6PD constitutes a central node linking carbon flux, redox homeostasis, and cell fate decisions, and remains a sustained focus in immunometabolism, cancer metabolism, functional interpretation of genetic variants, and methodological assay platforms.
Keywords: G6PD; pentose phosphate pathway; NADPH; redox homeostasis; glutathione; thioredoxin; metabolic reprogramming; isotope tracing; enzymatic assay; methodological standardization
I. Core Concepts and Metabolic Positioning
1.1 Reaction Definition and Stoichiometry
(1) Catalytic reaction
The G6PD-catalyzed reaction can be written as:
G6P + NADP⁺ → 6-phosphoglucono-δ-lactone (6-PGL) + NADPH + H⁺.
This step is commonly regarded as the entry reaction of the oxidative phase of the PPP.
(2) Metabolic positioning
Beyond NADPH generation, the oxidative PPP provides precursors for subsequent pentose phosphate production. The pathway is carbon-skeleton–connected to glycolysis, enabling dynamic flux allocation among energy production, biosynthetic precursor supply, and antioxidant demand.
1.2 Biological Implications of PPP Flux Allocation
(1) Plasticity between ribose demand and reducing-power demand
When nucleotide synthesis is the dominant requirement, the PPP is biased toward ribose-5-phosphate provision. When antioxidant defense and reductive power are prioritized, oxidative PPP flux increases to enhance NADPH output.
(2) Competition and complementarity with glycolysis
G6P can enter glycolysis to generate energy and intermediates or enter the PPP to produce NADPH and pentoses. This branch point shapes metabolic phenotypes in proliferation, inflammatory activation, hypoxia–reoxygenation, and drug-induced stress.
1.3 Major Uses of NADPH
(1) Electron supply for antioxidant systems
Provides reducing equivalents to glutathione reductase and thioredoxin reductase, sustaining the GSH/GSSG balance and Trx (reduced/oxidized) balance.
(2) Reductive power for anabolic metabolism
Supports fatty acid and cholesterol biosynthesis, reactions coupled to nucleotide metabolism, and parts of amino acid metabolism.
(3) Redox-associated effector processes
Supplies reducing equivalents to NADPH oxidases (NOX) for oxidative burst in immune cells and certain signaling processes; also contributes reducing power to cytochrome P450–related metabolic systems.
II. Molecular Structure and Enzymological Features
2.1 Conformation, Oligomeric State, and Stability
(1) Oligomeric state
G6PD commonly functions as a dimer or tetramer. Oligomer formation and interfacial stability affect catalytic efficiency, thermal stability, and sensitivity to oxidative environments.
(2) Stability–function coupling
Some functional deficits do not arise from direct catalytic-site inactivation but from reduced folding stability, increased propensity for oligomer dissociation, or stress-induced inactivation, leading to compromised redox maintenance capacity under pressure conditions.
2.2 Key Binding Sites and Kinetic Essentials
(1) Substrate-binding site
The G6P-binding site determines Km and the substrate-saturation window. Under high G6P availability, increased substrate supply can elevate PPP entry flux.
(2) Cofactor-binding site
NADP⁺ participates in catalytic electron transfer and may also stabilize enzyme conformation. Consequently, NADP⁺ concentration, ionic conditions, and sample handling can influence apparent activity and kinetic parameters.
2.3 Common Factors Shaping Enzymatic Phenotypes
(1) Temperature and buffering system
Temperature affects both catalytic rate and conformational stability. Buffer composition and ionic strength can modulate cofactor binding and protein-interface stability.
(2) Protein purity and inhibitory interference
Other dehydrogenases, reducing small molecules, or chelators in samples may interfere with NADPH readouts or alter activity. High-confidence assays require explicit background-correction strategies.
2.4 Experimental Entry Points for Structure–Function Analysis
(1) Catalytic-site–related variant dissection
Site-directed mutagenesis plus kinetic profiling can distinguish altered substrate affinity from altered catalytic efficiency.
(2) Stability-related variant dissection
Thermal stability curves, oligomeric-state analysis, and stress-condition activity-decay curves can quantify structural fragility contributions to phenotype.
III. Intracellular Regulation Layers and Metabolic Coupling
3.1 Transcriptional and Expression-Level Regulation
(1) Coupling to nutrient and growth signals
When anabolic demand rises or proliferative signaling is enhanced, PPP-related gene expression often increases to meet nucleotide and NADPH requirements.
(2) Coupling to oxidative stress
Under elevated oxidative pressure, cells can upregulate PPP entry and antioxidant networks to expand reducing-power reserves as an adaptive stress response.
3.2 Post-translational Modifications and Activity Control
(1) Modulation of conformation and interfaces
Post-translational modifications can alter local conformation, oligomeric interfaces, or cofactor-binding microenvironments, thereby affecting activity and stability.
(2) Coupling to metabolic state
Changes in energy and redox states are often accompanied by remodeling of modification landscapes, influencing G6PD flux and cellular redox thresholds.
3.3 Metabolite and Redox-Ratio–Driven Control
(1) NADP⁺/NADPH ratio
This ratio constrains reaction driving force and flux ceiling and serves as a direct control variable for G6PD output.
(2) G6P supply and carbon-flow allocation
Glycolytic rate, glycogenolysis, and glucose uptake jointly determine the G6P pool size, shaping substrate availability and PPP flux responsiveness.
3.4 Coupling to Organelle and Process-Level Demands
(1) Lipid biosynthesis demand
When fatty acid synthesis and membrane biogenesis increase, elevated NADPH demand can drive higher PPP flux.
(2) Detoxification and metabolic burden
During increased drug metabolism or reactive metabolite handling, NADPH demand can rise via multiple pathways, with the PPP often being a major contributor.
IV. The NADPH Network and Redox Homeostasis
4.1 Core Coupling to the Glutathione System
(1) Key chain
G6PD → NADPH → glutathione reductase → GSH regeneration → peroxide clearance (e.g., GPx).
(2) Quantifiable indices
GSH/GSSG ratio, H2O2 clearance capacity, lipid peroxidation levels, and protein thiol oxidation are commonly used to profile the functional state of this chain.
4.2 Thioredoxin System and Proteostasis
(1) Signaling regulation
The thioredoxin system regulates cysteine states of multiple redox-sensitive transcription factors and signaling proteins, shaping transcriptional programs and stress responses.
(2) Protein folding and quality control
Insufficient reducing power can promote protein misfolding and stress responses, shifting cellular survival thresholds.
4.3 Dual Roles of NADPH in Defense and Effector Functions
(1) Defensive arm
Reduces ROS burden and oxidative damage via the GSH/Trx systems.
(2) Effector arm
Supplies reducing equivalents to NOX and related systems for oxidative burst and selected signaling processes. Thus, in immune contexts, NADPH can simultaneously limit oxidative injury and support oxidative effector functions.
4.4 Links to Lipid Peroxidation and Cell-Death Pathways
(1) Ferroptosis-related risk
When insufficient reducing power prevents effective clearance of lipid peroxides, ferroptosis-like phenotypes may be enhanced.
(2) Mitochondrial injury and stress-associated apoptosis
Sustained oxidative pressure can trigger mitochondrial damage and stress-apoptosis pathway activation; by controlling reducing reserves, G6PD influences threshold setting.
V. Cell-Type–Specific Functions and Representative Biological Contexts
5.1 Erythrocytes
(1) Metabolic context
Erythrocytes lack mitochondria, making the PPP a major NADPH source; thus, G6PD is highly determinant for erythrocyte antioxidant capacity.
(2) Typical endpoints
Membrane lipid peroxidation, hemoglobin oxidation status, hemolysis sensitivity, and stability under stress.
5.2 Hepatocytes and Adipocytes
(1) Anabolic demand
Fatty acid and cholesterol synthesis depend on NADPH; PPP and other NADPH sources jointly shape anabolic capacity and metabolic phenotypes.
(2) Typical endpoints
Lipid-synthesis flux, lipid droplet formation, oxidative-stress tolerance, and metabolic–inflammatory coupling indices.
5.3 Immune Cell Activation and Inflammatory Metabolism
(1) Activation-associated metabolic reprogramming
Immune activation involves carbon-flow redistribution and redox remodeling; PPP flux changes often correlate with cytokine programs, phagocytic function, and oxidative burst.
(2) Typical endpoints
Cytokine expression, ISG programs, phagocytosis capacity, ROS-associated readouts, and integrated PPP-flux analyses.
5.4 Proliferating Cells and Cancer Metabolism
(1) Nucleotide and reducing-power demand
Rapidly proliferating cells require higher nucleotide supply and reducing reserves; PPP upregulation and increased G6PD activity are common metabolic phenotypes.
(2) Typical endpoints
Proliferation rate, nucleotide-pool changes, oxidative-stress tolerance, lipid-synthesis dependence, and differential drug sensitivity.
5.5 Stem Cells and Differentiation Systems
(1) State dependence
During stem-cell maintenance and differentiation, systemic shifts in redox homeostasis and metabolic flux occur; G6PD flux participates in redox-threshold setting.
(2) Typical endpoints
Self-renewal capacity, differentiation efficiency, stress sensitivity, and metabolic-state markers.
VI. Genetic Variants and Functional Consequences
6.1 Major Mechanistic Classes of Functional Defects
(1) Catalytic-efficiency–altered type
Variants affect substrate/cofactor binding or catalytic conformations, resulting in reduced Vmax, altered Km, or higher environmental sensitivity.
(2) Structural-stability–reduced type
Variants reduce folding quality or oligomer-interface stability, increasing stress-induced inactivation and lowering redox maintenance capacity under stress.
6.2 Building Evidence Chains for Variant Functional Interpretation
(1) Genetic perturbation
Knockdown/knockout and allele-specific expression systems help separate expression-level effects from intrinsic protein-property effects.
(2) Closed-loop phenotypic indices
Measure enzyme activity, NADPH/NADP⁺, GSH/GSSG, ROS, and lipid peroxidation in parallel, and integrate survival curves and functional readouts to close the phenotype loop.
6.3 Model-System Choice and Interpretability
(1) Cell models
Suitable for mechanistic deconvolution and rescue experiments; culture conditions must be controlled for system-wide effects on PPP flux.
(2) Animal and tissue models
Suitable for tissue-specific and systemic-effect evaluation; attention is required for tissue-to-tissue differences in NADPH sources and compensatory pathway reprogramming.
6.4 Connections to Drug Sensitivity and Population Heterogeneity
(1) Stress sensitivity
Differences in G6PD function shift tolerance thresholds to oxidative stress and drug-induced redox perturbation.
(2) Study strategy
A genotype–enzyme activity–redox phenotype–functional endpoint four-layer linked design improves interpretability and translatability.
VII. Methodology for Measurement and Characterization
7.1 Classical A340 Enzyme Activity Assay
(1) Principle
Use the increase in NADPH absorbance at 340 nm as the readout and convert ΔA340/time into enzyme activity units.
(2) Key control points
Fix buffer system, temperature, and NADP⁺ and G6P concentrations; normalize protein input; correct for hemolysis, reducing small molecules, or other dehydrogenase backgrounds using matched controls and blanks.
7.2 Linked Quantification of Intracellular Redox Indices
(1) NADPH/NADP⁺ and GSH/GSSG
Profiles reducing reserves and antioxidant-network load; sample-processing time and temperature control must be strictly standardized.
(2) ROS and lipid peroxidation
ROS probes and lipid-peroxidation outputs indicate stress directionality and should be cross-validated with antioxidant-network indices.
7.3 Isotope Tracing and Flux Analysis
(1) Why flux evidence is necessary
Steady-state NADPH levels are not equivalent to PPP flux, especially under compensatory-pathway activation, where interpretive bias is common.
(2) Strategy essentials
^13C tracing can resolve carbon allocation between PPP and glycolysis and estimate G6PD contribution to NADPH supply; integration with metabolomics improves resolution.
7.4 Specificity and Causality Validation
(1) Genetic and pharmacological cross-validation
Combining knockdown/knockout, rescue expression, and inhibitor perturbations substantially increases causal inference strength.
(2) Control of alternative pathways
Measure other NADPH sources (e.g., IDH1/2, ME1) and antioxidant enzyme networks in parallel to identify compensation and refine interpretive boundaries.
VIII. Research Use Cases and Typical Applications
8.1 Redox Homeostasis and Stress-Tolerance Studies
(1) Application logic
Modulate G6PD activity to alter NADPH supply and evaluate homeostasis maintenance under peroxide exposure, drug-induced oxidative stress, hypoxia–reoxygenation, or inflammatory stimulation.
(2) Common endpoints
Survival curves, GSH/GSSG, lipid peroxidation, mitochondrial function indices, DNA oxidative damage markers, and stress-pathway activation.
8.2 Metabolic Reprogramming and Proliferation Dependence
(1) Application logic
Use G6PD as the PPP-entry control point to dissect coupling among nucleotide synthesis, lipid synthesis, and antioxidant demand, and to identify metabolic vulnerabilities.
(2) Common endpoints
Proliferation rate, cell-cycle distribution, nucleotide pools, lipidomics features, metabolic flux changes, and shifts in drug sensitivity.
8.3 Immunometabolism and Inflammatory Signaling
(1) Application logic
Quantify PPP flux remodeling during immune activation and its coupling to cytokine programs, phagocytic function, oxidative burst, and redox homeostasis.
(2) Common endpoints
Cytokine expression, ISG programs, phagocytosis and killing capacity, NOX-related readouts, and integrated modeling of flux plus redox indices.
8.4 Drug Screening and Toxicology-Oriented Redox Modules
(1) Screening value
The G6PD/NADPH axis can serve as a redox-homeostasis module to screen compounds that induce oxidative pressure or alter reducing-power supply and to stratify mechanisms.
(2) Toxicological relevance
Redox perturbation and metabolic stress are common toxicity sources; early-stage redox-risk assessment using G6PD flux and NADPH-network readouts has methodological value.
8.5 In Vitro Assay Modules and Platform Development
(1) Standardized reaction modules
G6PD reaction systems can support dehydrogenase-module development, instrument calibration, stability testing, and high-throughput readout construction.
(2) Sample stratification and QC
In erythrocyte-related and stress-sensitivity research, G6PD activity can serve as a functional stratification index for grouping and quality control.
IX. Experimental Design Essentials
9.1 Core Design Principles
(1) Joint interpretation of flux evidence and steady-state indices
Interpret PPP flux evidence together with NADPH/NADP⁺ and GSH/GSSG steady-state indices to avoid single-metric inference.
(2) Standardization and documentation of culture conditions
Cell density, nutrient status, oxygen tension, medium composition, and serum lot can reshape PPP flux and redox background and should be fixed and fully recorded at the protocol level.
(3) Building a causal closed loop
Evidence chains integrating genetic perturbation, pharmacological validation, rescue experiments, and multidimensional redox readouts improve reproducibility and interpretability.
9.2 Common Error Sources and Mitigation
(1) Equating steady-state NADPH directly with G6PD flux changes
Account for alternative NADPH sources and changes in consumption that can shift steady-state levels.
(2) Ignoring rapid NADPH decay during sample handling
Implement strict time control and temperature control and enforce uniform handling.
(3) Using ROS-probe signals as the sole redox evidence
Cross-validate with GSH/GSSG, lipid peroxidation, and antioxidant-network indices.
X. Aladdin-Related Products
10.1 Overview of G6PD-Related Products
Catalog No. | Product Name | Grade and Purity | Application Area |
Glucose-6-Phosphate Dehydrogenase from Leuconostoc mesenteroides(High-Activity,Suspension) | EnzymoPure™, ≥600 NAD units/mg protein | Enzymatic assays; redox homeostasis experiments; NADPH flux analysis | |
Glucose-6-Phosphate Dehydrogenase (G6PD) | ActiBioPure™, Bioactive, High Performance, ≥95%(SDS-PAGE), ≥600 U/mg protein | High-precision activity assays; flux validation; antioxidant and drug-metabolism research | |
Glucose-6-phosphate Dehydrogenase from Leuconostoc mesenteroides(Suspension) | Bioactive, ActiBioPure™, High Performance, EnzymoPure™, ≥360 NAD units/mg protein | Flux analysis; cell models; metabolic-intervention validation | |
Glucose-6-phosphate Dehydrogenase from Leuconostoc mesenteroides(Lyophilized) | EnzymoPure™, ≥360 NAD units/mg protein | Enzymatic standards; long-term storage; high-throughput activity testing | |
Glucose-6-phosphate Dehydrogenase from Leuconostoc mesenteroides | EnzymoPure™, ≥200 NADP units/mg protein | Routine activity assays; intracellular NADPH flux analysis | |
Glucose-6-phosphate Dehydrogenase from Leuconostoc mesenteroides(Suspension) | EnzymoPure™, ≥200 NADP units/mg protein | Enzymology analysis; flux studies; cell experiments |
10.2 Key Reagents for G6PD Studies and NADPH Homeostasis Experiments
Category | Reagent | CAS No. | Applicable Experiment | Role in the System | Practical Notes |
Substrate / enzymatic assay | Glucose-6-phosphate (G6P) | G6PD enzyme kinetics | Catalytic substrate for G6PD | Measure ΔA340 with NADP⁺; use concentration gradients to optimize Km determination | |
Cofactor | NADPH | Redox homeostasis experiments | Reducing equivalent; assay calibration | Avoid prolonged air exposure; store cold | |
Antioxidant system | Reduced glutathione (GSH) | NADPH homeostasis and oxidative-stress assays | Redox buffering; radical scavenging | Pair with activity measurements; avoid oxidation | |
Antioxidant system | Oxidized glutathione (GSSG) | Redox-state evaluation | Oxidative stress mimic | Control pH; avoid degradation | |
Antioxidant system | L-Ascorbic acid | Protection of NADPH redox systems | Mild reductant | Light-protected handling | |
Fluorescent probe | DCFH-DA | ROS readouts linked to G6PD | ROS-sensitive fluorescence | Protect from light; hydrolyze/activate immediately before use | |
Enzyme regulation validation | 6-Aminoglucose | G6PD structure–function validation | Substrate-binding-site mimic | Pay attention to solubility | |
Oxidative stress model | Hydrogen peroxide (H2O2) | ROS challenge and G6PD response | Oxidative stress simulation | Use concentration gradients; avoid over-challenge | |
Metal ion modulation | ZnCl2 | Cofactor-environment effects on G6PD | Ionic-strength and activity modulation | Avoid excess to prevent precipitation | |
Metal ion modulation | MgCl2 | Supports G6PD catalytic activity | Conformational stabilization | Match with substrate/buffer conditions | |
Fluorogenic substrate | Resazurin | NADPH-dependent reductive readout | Fluorescent generation for quantification | Protect from light; avoid spontaneous reduction | |
Antioxidant auxiliary | β-Mercaptoethanol | Redox-system protection | Maintains reducing environment | Control concentration | |
Antioxidant auxiliary | DTT | Redox experiment control | Thiol protection | Store cold; protect from light | |
Antioxidant mimic | Trolox | NADPH-dependent redox systems | Water-soluble vitamin E analog | Protect from light | |
Antioxidant mimic | Lipoic acid | Reducing-power mimic | NADPH-linked defense modeling | Solvent selection matters | |
ROS scavenger | Catalase | H2O2 removal | Controls ROS background | Calibrate by activity units | |
ROS scavenger | Superoxide dismutase | Superoxide removal | Reduces oxidative interference | Calibrate by activity units | |
NADPH detection | WST-1 | NADPH-dependent reductive readout | Colorimetric/fluorometric readout | Protect from light |
By controlling PPP entry flux, G6PD shapes NADPH supply and anabolic capacity, serving as a key node in redox homeostasis and metabolic phenotype formation. Establishing standardized methodological frameworks around activity assays, flux validation, and multidimensional redox indices can improve analytical precision and reproducibility for G6PD-related mechanisms and intervention-effect evaluation.